Substantial evidence suggests that androgenic anabolic steroids (AAS) have deleterious effects on many body tissues, but their influence on endogenous mechanisms of cardioprotection is poorly understood. In the current issue of CDT, Marques-Neto et al. present a study examining the mechanisms by which AAS attenuate the protective effects of exercise training on myocardial ischemia/ reperfusion injury [1] . They chose to focus on the roles of angiotensin II and aldosterone, given the wellestablished stimulatory effect of AAS on the renin angiotensin-aldosterone system (RAAS) and the role of this system in the pathogenesis of myocardial injury. Exercise-trained rats were co-administered nandralone (AAS) along with losartan or spironolactone to block AT 1 or aldosterone receptors, followed by evaluation of post-ischemic function and infarct size in isolated perfused hearts. Their results show that nandralone abolishes the benefits of exercise training on post-ischemic function and infarct size reduction, and that both RAAS blockers restore these benefits, confirming the hypothesized role of the RAAS in the AAS-induced suppression of exercise-induced cardioprotection.
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In this study, Marques-Neto et al. link the preservation of cardioprotection to maintenance of myocardial sarcolemmal ATP-sensitive potassium (sarcK ATP ) channel expression. sarcK ATP channels are highly expressed in the cardiac sarcolemma, and open in response to local changes in nucleotide content (reviewed in [2] [3] [4] ). A growing body of literature supports a positive correlation between sarcK ATP expression and cardioprotection [5, 6] . Preconditioning conferred by exercise is associated with enhanced sarcK ATP channel subunits [7] , and genetic loss of sarcK ATP channels confers exercise intolerance and poor adaptation of the heart to stress [8] .
sarcK ATP channel expression is also believed to mediate sex-dependent protection against cardiac injury. While women are known to exhibit reduced risk of cardiovascular events and associated mortality compared to males, the molecular mechanisms of this sex-dimorphism remains incompletely understood [9] [10] [11] . Animal studies have demonstrated an intrinsic resistance of the female heart to ischemia/ reperfusion injury, which has been linked to a higher expression of sarcK ATP channel subunits in the female versus male heart [6, [12] [13] [14] . Estrogen upregulates sarcK ATP channel subunit expression in cardiomyocytes [15] , suggesting a potential mechanism for its protective effects in the heart. Clinical studies indicate that pharmacological interventions that block sarcK ATP channels to manage disease symptoms are associated with increased cardiovascular mortality [16, 17] , further suggesting an important protective role of these channels on cardiovascular health.
Despite the relationship between cardiac tissue health and sarcK ATP expression, the cellular mechanisms responsible for altering the expression of these channels are not clear. The study by Marques-Neto et al. implicates the RAAS in androgenic suppression of sarcK ATP and exercise-induced cardioprotection. This adds to an ever-growing list of pathogenic effects mediated by hyperactivity of this system, including maladaptive cardiac remodeling, kidney failure, vascular endothelial dysfunction, and hypertension. Estrogen has been shown to attenuate the pathogenic effects of RAAS on these pathologies [18] , implicating their interaction in the cardioprotected female phenotype. Interestingly, sarcK ATP channel activation attenuates the effects of RAAS activation on maladaptive cardiac remodeling and endothelial dysfunction [5, 19] , processes known to exhibit sex-dimorphic risk profiles [11, 20, 21] .
It is intriguing to speculate that sarcK ATP channel activity is required for other protective effects of estrogen and female sex on the cardiovascular system. This hypothesis merits further investigation, as such studies may reveal new therapeutic applications for sarcK ATP channel openers and shed light on the molecular underpinnings of cardiovascular sexdimorphisms. Another exciting area for future study is to determine the involvement of other intracellular receptors that respond to RAAS signaling. For example, recent work identified a mitochondrial angiotensin receptor [22] , which may be centrally involved in several paradigms of cardioprotection by influencing nitric oxide-dependent signaling. Finally, studies aimed at elucidating the interaction of estrogens, androgens and RAAS signaling on sarcK ATP channel expression may help to unravel the complex biological effects of these systems that could simplify future thinking and improve therapeutic approaches to cardiovascular disease.
